406 related articles for article (PubMed ID: 16229921)
1. Mouse livers with macrosteatosis are more susceptible to normothermic ischemic injury than those with microsteatosis.
Selzner N; Selzner M; Jochum W; Amann-Vesti B; Graf R; Clavien PA
J Hepatol; 2006 Apr; 44(4):694-701. PubMed ID: 16229921
[TBL] [Abstract][Full Text] [Related]
2. The effects of N-acetylcysteine and anti-intercellular adhesion molecule-1 monoclonal antibody against ischemia-reperfusion injury of the rat steatotic liver produced by a choline-methionine-deficient diet.
Nakano H; Nagasaki H; Barama A; Boudjema K; Jaeck D; Kumada K; Tatsuno M; Baek Y; Kitamura N; Suzuki T; Yamaguchi M
Hepatology; 1997 Sep; 26(3):670-8. PubMed ID: 9303498
[TBL] [Abstract][Full Text] [Related]
3. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
[TBL] [Abstract][Full Text] [Related]
4. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids.
El-Badry AM; Moritz W; Contaldo C; Tian Y; Graf R; Clavien PA
Hepatology; 2007 Apr; 45(4):855-63. PubMed ID: 17393510
[TBL] [Abstract][Full Text] [Related]
5. Prevention of I/R injury in fatty livers by ischemic preconditioning is associated with increased mitochondrial tolerance: the key role of ATPsynthase and mitochondrial permeability transition.
Rolo AP; Teodoro JS; Peralta C; Rosello-Catafau J; Palmeira CM
Transpl Int; 2009 Nov; 22(11):1081-90. PubMed ID: 19619169
[TBL] [Abstract][Full Text] [Related]
6. Heat shock preconditioning ameliorates liver injury following normothermic ischemia-reperfusion in steatotic rat livers.
Yamagami K; Yamamoto Y; Kume M; Kimoto S; Yamamoto H; Ozaki N; Yamamoto M; Shimahara Y; Toyokuni S; Yamaoka Y
J Surg Res; 1998 Sep; 79(1):47-53. PubMed ID: 9735239
[TBL] [Abstract][Full Text] [Related]
7. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
[TBL] [Abstract][Full Text] [Related]
8. Steatotic liver transplantation in the mouse: a model of primary nonfunction.
Birsner JH; Wan C; Cheng G; Evans ZP; Polito CC; Fiorini RN; Gilbert G; Haines JK; Schmidt MG; Chavin KD
J Surg Res; 2004 Jul; 120(1):97-101. PubMed ID: 15172195
[TBL] [Abstract][Full Text] [Related]
9. Increased ischemic injury in old mouse liver: an ATP-dependent mechanism.
Selzner M; Selzner N; Jochum W; Graf R; Clavien PA
Liver Transpl; 2007 Mar; 13(3):382-90. PubMed ID: 17318856
[TBL] [Abstract][Full Text] [Related]
10. Chemical composition of hepatic lipids mediates reperfusion injury of the macrosteatotic mouse liver through thromboxane A(2).
El-Badry AM; Jang JH; Elsherbiny A; Contaldo C; Tian Y; Raptis DA; Laczko E; Moritz W; Graf R; Clavien PA
J Hepatol; 2011 Dec; 55(6):1291-9. PubMed ID: 21703192
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
Jamieson RW; Zilvetti M; Roy D; Hughes D; Morovat A; Coussios CC; Friend PJ
Transplantation; 2011 Aug; 92(3):289-95. PubMed ID: 21681143
[TBL] [Abstract][Full Text] [Related]
12. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
[TBL] [Abstract][Full Text] [Related]
13. Ischemia-reperfusion injury in rat fatty liver: role of nutritional status.
Caraceni P; Nardo B; Domenicali M; Turi P; Vici M; Simoncini M; De Maria N; Trevisani F; Van Thiel DH; Derenzini M; Cavallari A; Bernardi M
Hepatology; 1999 Apr; 29(4):1139-46. PubMed ID: 10094958
[TBL] [Abstract][Full Text] [Related]
14. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
15. Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury.
Baskin-Bey ES; Canbay A; Bronk SF; Werneburg N; Guicciardi ME; Nyberg SL; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G396-402. PubMed ID: 15472011
[TBL] [Abstract][Full Text] [Related]
16. Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice.
Fiorini RN; Donovan JL; Rodwell D; Evans Z; Cheng G; May HD; Milliken CE; Markowitz JS; Campbell C; Haines JK; Schmidt MG; Chavin KD
Liver Transpl; 2005 Mar; 11(3):298-308. PubMed ID: 15719408
[TBL] [Abstract][Full Text] [Related]
17. Sinusoidal flow block after warm ischemia in rats with diet-induced fatty liver.
Hakamada K; Sasaki M; Takahashi K; Umehara Y; Konn M
J Surg Res; 1997 Jun; 70(1):12-20. PubMed ID: 9228921
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids reduce hepatic steatosis and consequently attenuate ischemia-reperfusion injury following partial hepatectomy in rats.
Marsman HA; Heger M; Kloek JJ; Nienhuis SL; ten Kate FJ; van Gulik TM
Dig Liver Dis; 2011 Dec; 43(12):984-90. PubMed ID: 21840275
[TBL] [Abstract][Full Text] [Related]
19. Fatty liver in liver transplantation and surgery.
Selzner M; Clavien PA
Semin Liver Dis; 2001; 21(1):105-13. PubMed ID: 11296690
[TBL] [Abstract][Full Text] [Related]
20. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition?
Yang S; Lin HZ; Hwang J; Chacko VP; Diehl AM
Cancer Res; 2001 Jul; 61(13):5016-23. PubMed ID: 11431335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
